Outcome after treatment of papillary thyroid microcarcinoma
- PMID: 12148571
Outcome after treatment of papillary thyroid microcarcinoma
Abstract
Patients with thyroid microcarcinoma (TMC) have favourable long-term prognoses. However, recurrences in the neck and distant metastases have been reported. The authors investigated independent factors associated with recurrence in an effort to define therapeutic guidelines. In this study they report the results of a retrospective review of patients followed at one Institution. 120 patients ( 96 females and 24 males; mean age 45.2 years) with a papillary thyroid microcarcinoma (PTC) < or =1 cm in greatest dimension were analyzed. All of them were followed for 5 to 15 years. 106 of them were managed aggressively (total thyroidectomy), the remainder treated with lobectomy alone. Radioiodine therapy was performed in 62/106 patients submitted to total thyroidectomy. Despite the different treatment and the presence of neck node metastases at the time of the diagnosis in 26 of the reported 120 patients (22%) and local invasion beyond the thyroid capsule in 20 (17%), only 1.7% of patients had neck nodal local recurrence. No patient died or developed distant metastases. In this preliminary study the authors conclude that the outcome of PMC is generally favourable, even in presence of lymph-node metastases and local invasion, independently of the primary treatment.
Similar articles
-
Treatment for microcarcinoma of the thyroid--clinical experience.Clin Nucl Med. 2007 Apr;32(4):279-81. doi: 10.1097/01.rlu.0000257272.90126.3d. Clin Nucl Med. 2007. PMID: 17413573
-
Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality.Cancer. 2003 Jul 1;98(1):31-40. doi: 10.1002/cncr.11442. Cancer. 2003. PMID: 12833452
-
Improving postoperative recurrence rates for carcinoma of the thyroid gland.Surg Gynecol Obstet. 1989 Nov;169(5):429-34. Surg Gynecol Obstet. 1989. PMID: 2814754
-
Papillary thyroid microcarcinoma: a surgical perspective.Cancer Treat Rev. 2005 Oct;31(6):423-38. doi: 10.1016/j.ctrv.2005.04.009. Epub 2005 Jul 6. Cancer Treat Rev. 2005. PMID: 16005155 Review.
-
Management of papillary microcarcinoma of the thyroid.S D Med. 2006 Oct;59(10):425-7. S D Med. 2006. PMID: 17124919 Review.
Cited by
-
Total surface area is useful for differentiating between aggressive and favorable multifocal papillary thyroid carcinomas.Yonsei Med J. 2015 Mar;56(2):355-61. doi: 10.3349/ymj.2015.56.2.355. Yonsei Med J. 2015. PMID: 25683981 Free PMC article.
-
Managing thyroid microcarcinomas.Yonsei Med J. 2012 Jan;53(1):1-14. doi: 10.3349/ymj.2012.53.1.1. Yonsei Med J. 2012. PMID: 22187228 Free PMC article. Review.
-
Total Thyroidectomy Versus Lobectomy for Thyroid Cancer: Single-Center Data and Literature Review.Ann Surg Oncol. 2021 Aug;28(8):4334-4344. doi: 10.1245/s10434-020-09481-8. Epub 2021 Feb 10. Ann Surg Oncol. 2021. PMID: 33566240 Free PMC article. Review.
-
Evaluation of surgical risk and prognosis between thyroid nodules of size <1 and ≥1 cm.Gland Surg. 2019 Dec;8(6):674-682. doi: 10.21037/gs.2019.11.11. Gland Surg. 2019. PMID: 32042675 Free PMC article.
-
'Aggressive papillary' thyroid microcarcinoma.Eur Arch Otorhinolaryngol. 2009 Dec;266(12):1959-63. doi: 10.1007/s00405-009-0952-5. Epub 2009 Mar 18. Eur Arch Otorhinolaryngol. 2009. PMID: 19294400
MeSH terms
Substances
LinkOut - more resources
Medical